Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Venous Thromboembolism × Nadroparin × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1 Classical hematology 1

Conditions

Venous Thromboembolism 1 Lung Neoplasms 1 Esophageal Neoplasms 1

Interventions

Rivaroxaban 3 apixaban 2 Fondaparinux 2 Enoxaparin 2 enoxaparin sodium 1 edoxaban 1 Warfarin 1 Tinzaparin 1 Nadroparin 1 Long-Term Synaptic Depression 1 Heparin, Low-Molecular-Weight 1 Hematologic Tests 1 Educational Status 1 Dalteparin 1 Dabigatran 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01267305 2014-04-29

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

Shanghai Zhongshan Hospital

Phase NA Completed

Classical hematologyGastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡